Automated Tumor Count for Mitosis-Karyorrhexis Index Determination in Neuroblastoma Using Whole Slide Image and Qupath, an Image Analytic Software

Author:

Yu Guizhen1,Yu Chao2,Xie Feng3,He Mai4ORCID

Affiliation:

1. Data Science Program of Whiting School of Engineering, The Johns Hopkins University, Baltimore, MD, USA

2. Oak Brook Business Consulting, Eagan, MN, USA

3. Department of Communications Network Engineering & Analysis, The MITRE Corporation, McLean, VA, USA

4. Department of Pathology & Immunology, Washington University in St Louis School of Medicine, St Louis, MO, USA

Abstract

Introduction Mitosis-karyorrhexis index (MKI) is important for risk stratification workup of neuroblastic tumors. MKI is calculated by estimating the denominator (5000 tumor cells). We hypothesized that whole slide image (WSI) with appropriate digital image analytical software could provide an objective aid to pathologist’s MKI workup. Materials & Methods With IRB approval, sixteen cases of neuroblastic tumors as convenient cases were used. H&E slides were scanned at 40X using an Aperio Scanscope AT2 scanner and stored in SVS format. Digital photos were also taken and stored in TIFF format. Qupath, an open source image analytical software, was used to annotate, define region of interest (ROI) and automatically count the cells within ROI. Results With selected parameters, Qupath was able to provide cell count using both WSI (.svs) and digital images (.TIFF). Comparison of automated count and eyeball manual count generated precision above .96, recall above .96, F1 scores above .98, with false positive rate ranging from .6 to 3.7%, and false negative rate from .6 to 3.8%. Compared to original pathological report, automated tumor cell count led to lower MKI in 3 of 16 cases (18.8%) and change of “unfavorable histology” to “favorable” in one case (1/16, 6.3%). Conclusion Combination of WSI (or digital images) with Qupath is able to provide an automated, objective and consistent way for cell count to facilitate pathologist’s MKI determination in neuroblastic tumors’ workup and research.

Funder

Faculty Development Grant, Department of Pathology & Immunology, Washington University School of Medicine

Publisher

SAGE Publications

Subject

General Medicine,Pathology and Forensic Medicine,Pediatrics, Perinatology and Child Health

Reference12 articles.

1. The American Cancer Society medical and editorial content team. Key Statistics about Neuroblastoma. https://www.cancer.org/cancer/neuroblastoma/about/key-statistics.html. (Assessed 30 April 2022)

2. The Evolution of Risk Classification for Neuroblastoma

3. Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas

4. Terminology and morphologic criteria of neuroblastic tumors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3